Steadfast Capital Management LP Has Raised Wells Fargo & Co New (WFC) Holding By $198.06 Million; Charles Riv Labs International (CRL) Shorts Increased By 2.77%

August 27, 2017 - By Darrin Black

Steadfast Capital Management Lp increased Wells Fargo & Co New (WFC) stake by 375.31% reported in 2016Q4 SEC filing. Steadfast Capital Management Lp acquired 3.60 million shares as Wells Fargo & Co New (WFC)’s stock declined 8.66%. The Steadfast Capital Management Lp holds 4.56M shares with $251.33 million value, up from 959,500 last quarter. Wells Fargo & Co New now has $256.98 billion valuation. The stock decreased 0.75% or $0.39 on August 25, reaching $51.77. About 15.31M shares traded. Wells Fargo & Co (NYSE:WFC) has risen 9.67% since August 27, 2016 and is uptrending. It has underperformed by 7.03% the S&P500.

Charles Riv Labs International Incorporated (NYSE:CRL) had an increase of 2.77% in short interest. CRL’s SI was 1.43 million shares in August as released by FINRA. Its up 2.77% from 1.39M shares previously. With 273,600 avg volume, 5 days are for Charles Riv Labs International Incorporated (NYSE:CRL)’s short sellers to cover CRL’s short positions. The SI to Charles Riv Labs International Incorporated’s float is 3.04%. The stock increased 0.04% or $0.04 on August 25, reaching $105.03. About 428,326 shares traded or 26.93% up from the average. Charles River Laboratories Intl. Inc (NYSE:CRL) has risen 7.06% since August 27, 2016 and is uptrending. It has underperformed by 9.64% the S&P500.

Among 11 analysts covering Charles River Laboratories (NYSE:CRL), 5 have Buy rating, 1 Sell and 5 Hold. Therefore 45% are positive. Charles River Laboratories had 26 analyst reports since August 3, 2015 according to SRatingsIntel. The stock of Charles River Laboratories Intl. Inc (NYSE:CRL) has “Sell” rating given on Tuesday, September 6 by UBS. The company was upgraded on Monday, October 12 by Wells Fargo. The rating was maintained by Citigroup with “Neutral” on Thursday, August 4. The rating was initiated by Gabelli on Tuesday, April 26 with “Buy”. The firm has “Buy” rating by Jefferies given on Tuesday, June 13. The rating was initiated by Credit Suisse with “Neutral” on Tuesday, June 21. Jefferies maintained Charles River Laboratories Intl. Inc (NYSE:CRL) on Friday, January 8 with “Buy” rating. The firm has “Underweight” rating by Barclays Capital given on Friday, May 20. The stock has “Equal Weight” rating by Barclays Capital on Wednesday, November 30. The firm has “Buy” rating by Jefferies given on Monday, April 24.

Investors sentiment decreased to 0.89 in Q4 2016. Its down 0.22, from 1.11 in 2016Q3. It worsened, as 27 investors sold Charles River Laboratories Intl. Inc shares while 98 reduced holdings. 37 funds opened positions while 102 raised stakes. 44.60 million shares or 0.46% less from 44.81 million shares in 2016Q3 were reported. Nuveen Asset Management owns 22,862 shares. Tfs Capital Lc reported 12,461 shares or 0.25% of all its holdings. Balyasny Asset Management Ltd Liability Corp stated it has 256,104 shares. Princeton Alpha L P stated it has 0.05% of its portfolio in Charles River Laboratories Intl. Inc (NYSE:CRL). Northwestern Mutual Wealth Company has 82 shares for 0% of their portfolio. 846,324 were accumulated by Alyeska Invest Group Ltd Partnership. Guggenheim Capital Ltd Liability Corporation holds 0.02% or 76,670 shares. Retirement Of Alabama, a Alabama-based fund reported 88,618 shares. Ibm Retirement Fund owns 0.01% invested in Charles River Laboratories Intl. Inc (NYSE:CRL) for 3,719 shares. Ameritas Investment Prtn Inc has 0.06% invested in Charles River Laboratories Intl. Inc (NYSE:CRL) for 14,395 shares. Highland Capital Mngmt Ltd Liability owns 8,996 shares or 0.06% of their US portfolio. Jane Street Group Limited Liability Corporation holds 0% or 13,077 shares. Florida-based State Board Of Administration Of Florida Retirement Systems has invested 0.02% in Charles River Laboratories Intl. Inc (NYSE:CRL). Riverhead Cap Mngmt Limited Company owns 1,800 shares for 0.01% of their portfolio. Aperio Gp has invested 0.01% in Charles River Laboratories Intl. Inc (NYSE:CRL).

Charles River Laboratories International, Inc. is an early-stage contract research company. The company has market cap of $5.00 billion. The Firm is engaged in laboratory animal medicine and science and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its clients from target identification through non-clinical development. It has a 27.73 P/E ratio. The Firm operates in three divisions: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing).

Since February 28, 2017, it had 0 insider purchases, and 12 sales for $6.23 million activity. $286,254 worth of Charles River Laboratories Intl. Inc (NYSE:CRL) was sold by Molho Davide. On Tuesday, February 28 FOSTER JAMES C sold $439,887 worth of Charles River Laboratories Intl. Inc (NYSE:CRL) or 5,038 shares. $99,784 worth of Charles River Laboratories Intl. Inc (NYSE:CRL) was sold by MASSARO GEORGE on Friday, May 12. 1,900 shares were sold by Barbo William D, worth $167,014. $592,702 worth of stock was sold by BERTOLINI ROBERT J on Wednesday, March 1. $653,540 worth of Charles River Laboratories Intl. Inc (NYSE:CRL) shares were sold by JOHST DAVID P. 300 shares were sold by Kochevar Deborah Turner, worth $26,408 on Friday, May 12.

Among 31 analysts covering Wells Fargo & Company (NYSE:WFC), 13 have Buy rating, 5 Sell and 13 Hold. Therefore 42% are positive. Wells Fargo & Company had 84 analyst reports since July 29, 2015 according to SRatingsIntel. As per Friday, July 28, the company rating was maintained by Piper Jaffray. BMO Capital Markets maintained Wells Fargo & Co (NYSE:WFC) rating on Friday, July 14. BMO Capital Markets has “Sell” rating and $4900 target. The company was maintained on Friday, July 7 by Jefferies. The firm has “Buy” rating by RBC Capital Markets given on Thursday, June 22. The rating was maintained by FBR Capital on Tuesday, September 27 with “Outperform”. BMO Capital Markets maintained Wells Fargo & Co (NYSE:WFC) rating on Wednesday, May 31. BMO Capital Markets has “Sell” rating and $5000 target. The stock of Wells Fargo & Co (NYSE:WFC) earned “Buy” rating by Guggenheim on Wednesday, July 29. The rating was upgraded by Sandler O’Neill to “Buy” on Wednesday, September 2. The rating was downgraded by Sandler O’Neill to “Hold” on Monday, April 11. The firm earned “Strong-Buy” rating on Wednesday, September 2 by Vetr.

Since March 3, 2017, it had 1 buying transaction, and 7 selling transactions for $397.31 million activity. 24,708 Wells Fargo & Co (NYSE:WFC) shares with value of $1.34M were sold by Pelos Petros G. 9,050 shares were bought by SARGENT RONALD, worth $499,108 on Friday, May 5. Hardison Hope A. sold $1.04 million worth of stock. CARROLL DAVID M sold $1.47M worth of Wells Fargo & Co (NYSE:WFC) on Wednesday, March 22. Another trade for 20,000 shares valued at $1.04M was sold by Loughlin Michael J. Shares for $383.92M were sold by BERKSHIRE HATHAWAY INC. Shares for $2.05 million were sold by Mack Mary T on Thursday, June 8.